Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

CUDC-101 Overcomes Arsenic Trioxide Resistance Via Caspase-Dependent PML-Rarα Degradation in Acute Promyelocytic Leukemia

Tianzhuo Zhang, Jishi Wang, PhD

Blood (2019) 134 (Supplement_1): 5054.

https://doi.org/10.1182/blood-2019-131618

Published: 2019

Journal Articles

Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma

Mridul Roy, Long Liang, Xiaojuan Xiao, Yuanliang Peng, Yuhao Luo, Weihua Zhou, Ji Zhang, Lugui Qiu, Shuaishuai Zhang, Feng Liu, Xiuli An, MD PhD, Mao Ye, Wen Zhou, PhD, Jing Liu, PhD

Blood (2016) 128 (22): 3265.

https://doi.org/10.1182/blood.V128.22.3265.3265

Published: 2016

Journal Articles

The Oncolytic Measles Virus Preferentially Infects p53 Abnormal Myeloma Cells

Anne Lok, MD, Geraldine Descamps, PhD, Benoit Tessoulin, MD, Philippe Moreau, Steven Le Gouill, MD PhD, Frederic Tangy, PhD, Martine Amiot, Catherine Pellat-Deceunynck, PhD

Blood (2016) 128 (22): 310.

https://doi.org/10.1182/blood.V128.22.310.310

Published: 2016

Journal Articles

ONC212 Is a Potent Member of the Imipridone Class of Anti-Cancer Compounds That Induces p53-Independent Apoptosis in Hematological Malignancies

Takenobu Nii, PhD, Jo Ishizawa, MD PhD, Ran Zhao, Jianfang Zeng, MD PhD, Dhruv Chachad, Kensuke Kojima, MD PhD, Marina Konopleva, MD PhD, Richard Eric Davis, MD, Joshua E Allen, PhD, Martin Stogniew, PhD, Michael Andreeff, MD PhD

Blood (2016) 128 (22): 4059.

https://doi.org/10.1182/blood.V128.22.4059.4059

Published: 2016

Journal Articles

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Mediates and Sustains NF-κb Constitutive Activation in LGL Leukemia Cells

Jun Yang, MD, Francis R Leblanc, PhD, Shubha Dighe, MS, Susan B. Nyland, PhD, David J. Feith, PhD, Thomas P. Loughran, Jr., MD

Blood (2016) 128 (22): 2762.

https://doi.org/10.1182/blood.V128.22.2762.2762

Published: 2016

Journal Articles

Identification of Effective Targeted Drug Combinations Using Functional Ex Vivo Screening of Primary Patient Specimens

Stephen E Kurtz, PhD, Elie Traer, MD PhD, Jakki Martinez, Andrew Park, Jake Wagner, Ravi Pandya, PhD, William Bolosky, PhD, Brian J. Druker, MD, Jeffrey W. Tyner, PhD

Blood (2015) 126 (23): 865.

https://doi.org/10.1182/blood.V126.23.865.865

Published: 2015

Journal Articles

Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells

Cody Paiva, BS, Claire Godbersen, Stephen E Spurgeon, MD, Sreesha Srinivasa, Jennifer R Brown, MD PhD, Alexey V Danilov, MD PhD

Blood (2015) 126 (23): 1752.

https://doi.org/10.1182/blood.V126.23.1752.1752

Published: 2015

Journal Articles

Imipramine Blue Sensitively and Selectively Targets FLT3 and c-Kit Mutant Acute Myeloid Leukemia

Jonathan L. Metts, MD, Heath L. Bradley, M.S., Neil P. Shah, Reuben Kapur, PhD, Jack L. Arbiser, MD, PhD, Kevin D. Bunting, PhD

Blood (2015) 126 (23): 3688.

https://doi.org/10.1182/blood.V126.23.3688.3688

Published: 2015

Journal Articles

High-Throughput Drug Screening Identifies Pyrimethamine As a Potent and Selective Inhibitor of Acute Myeloid Leukemia

Amit Sharma, PhD, Nidhi Jyotsana, Courteney K. Lai, BSc, Anuhar Chaturvedi, PhD, Kerstin Görlich, Cecilia Murphy, Jan E. Blanchard, Arnold Ganser, Eric Brown, John A. Hassell, R. Keith Humphries, MD PhD, Michael A Morgan, PhD, Michael Heuser, MD

Blood (2014) 124 (21): 2304.

https://doi.org/10.1182/blood.V124.21.2304.2304

Published: 2014

Journal Articles

Bortezomib Is Highly Effective For Pure Red Cell Aplasia After ABO-Incompatible Hematopoietic Stem Cell Transplantation

Fatima Khan, MBBS, Michael A. Linden, MD, PhD, Nicole D. Zantek, M.D., Ph.D., Gregory M Vercellotti

Blood (2013) 122 (21): 5495.

https://doi.org/10.1182/blood.V122.21.5495.5495

Published: 2013

Journal Articles

Gene Expression Analysis Of Plasmablastic Lymphoma Identifies Down Regulation Of B Cell Receptor Signaling and Additional Unique Transcriptional Programs

Jennifer R. Chapman-Fredricks, MD, Andrew J. Gentles, PhD, Daxing Zhu, MD, Victoria Sujoy, MD, Izidore S Lossos, MD

Blood (2013) 122 (21): 3779.

https://doi.org/10.1182/blood.V122.21.3779.3779

Published: 2013

Journal Articles

Dysregulation, But Not Mutation Of p53 Signaling Pathway In Breast Implant-Associated Anaplastic Large Cell Lymphoma Cell Lines

Hai Wang, MD/PhD, Chao Xie, BS, Shiwu Li, PhD, Eva V. George, MD, Westley H. Reeves, MD, Alan L. Epstein, MD/PhD, Li-Jun Yang, MD

Blood (2013) 122 (21): 4879.

https://doi.org/10.1182/blood.V122.21.4879.4879

Published: 2013

Journal Articles

Enhancing Ceramide Cytotoxicity in Acute Myelogenous Leukemia

Timothy J Brown, B.S., Brian Barth, Ph.D., David F. Claxton, MD

Blood (2012) 120 (21): 4905.

https://doi.org/10.1182/blood.V120.21.4905.4905

Published: 2012

Journal Articles

SF3B1 Mutations in CLL Are Equivalent to p53/ATM Dysfunction and Cause Defective Puma Upregulation in Response to Chemotherapy

Doreen te Raa, MD, Ingrid AM Derks, Dieuwertje M Luijks, Jacoline van Laar, Hanneke Monsuur, Ceri Oldreive, Alexander Jethwa, Jennifer Hüllein, Tatjana Stankovic, MD PhD, Thorsten Zenz, MD, Marinus H.J. Van Oers, MD, PhD, Arnon P. Kater, MD PhD, Eric Eldering, PhD

Blood (2012) 120 (21): 711.

https://doi.org/10.1182/blood.V120.21.711.711

Published: 2012

Journal Articles

ABT-737 Sensitizes B Cell Tumors for Killing by CD19-Retargeted T Cells,

Hannah S C Karlsson, Camilla Lindqvist, PhD, Gabriella Paul-Wetterberg, Helena Jernberg Wiklund, PhD, Kenneth Nilsson, MD, PhD, Bengt Simonsson, MD, PhD, Per Frisk, MD, PhD, Angelica Loskog, PhD

Blood (2011) 118 (21): 4032.

https://doi.org/10.1182/blood.V118.21.4032.4032

Published: 2011

Journal Articles

Potent Synergistic Activity of the NAD+ Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.

Blood (2009) 114 (22): 2733.

https://doi.org/10.1182/blood.V114.22.2733.2733

Published: 2009

Journal Articles

Frequent Expression of MUC1, a Membrane-Associated Mucin, in Adult T-Cell Leukemia Cells.

Hiroo Hasegawa, Minori Komoda, Yasuaki Yamada, Suguru Yonezawa, Yasushi Miyazaki, Kunihiro Tsukasaki, Kazuhiro Nagai, Sunao Atogami, Akemi Osaka, Daisuke Sasaki, Kazuto Tsuruda, Shimeru Kamihira

Blood (2009) 114 (22): 1922.

https://doi.org/10.1182/blood.V114.22.1922.1922

Published: 2009

Journal Articles

Synergistic Apoptosis Induction by Betulinic Acid and Established Cytotoxic Drugs in Leukemia Cells.

Harald Ehrhardt, Ines Höfig, Irmela Jeremias

Blood (2009) 114 (22): 3096.

https://doi.org/10.1182/blood.V114.22.3096.3096

Published: 2009

Journal Articles

The Immunotoxin HM1.24-ETA′ Is a Potent Inducer of Apoptosis in Malignant Plasma Cells

Matthias Staudinger, Anja Muskulus, Renate Burger, Andreas Guenther, Roland Repp, Martin Gramatzki, Matthias Peipp

Blood (2008) 112 (11): 3658.

https://doi.org/10.1182/blood.V112.11.3658.3658

Published: 2008

Journal Articles

Dasatinib Is An Effective Inhibitor of Proliferation and Inducer of Apoptosis in the KASUMI Cell Line Bearing the T(8;21)(q22;q22) and the N822K KIT Mutation

Vassiliki Pappa, MD, F. Kontsioti, E. Liakata, S Papageorgiou, A. Spathis, P Tsirigotis, ED Ioannidou, C Economopoulou, S Chondropoulos, K Girkas, E Papageorgiou, P. Karakitsos, J Dervenoulas, T Economopoulos

Blood (2008) 112 (11): 5054.

https://doi.org/10.1182/blood.V112.11.5054.5054

Published: 2008

NARROW

CUDC-101 Overcomes Arsenic Trioxide Resistance Via Caspase-Dependent PML-Rarα Degradation in Acute Promyelocytic Leukemia

Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma

The Oncolytic Measles Virus Preferentially Infects p53 Abnormal Myeloma Cells

ONC212 Is a Potent Member of the Imipridone Class of Anti-Cancer Compounds That Induces p53-Independent Apoptosis in Hematological Malignancies

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Mediates and Sustains NF-κb Constitutive Activation in LGL Leukemia Cells

Identification of Effective Targeted Drug Combinations Using Functional Ex Vivo Screening of Primary Patient Specimens

Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells

Imipramine Blue Sensitively and Selectively Targets FLT3 and c-Kit Mutant Acute Myeloid Leukemia

High-Throughput Drug Screening Identifies Pyrimethamine As a Potent and Selective Inhibitor of Acute Myeloid Leukemia

Bortezomib Is Highly Effective For Pure Red Cell Aplasia After ABO-Incompatible Hematopoietic Stem Cell Transplantation

Gene Expression Analysis Of Plasmablastic Lymphoma Identifies Down Regulation Of B Cell Receptor Signaling and Additional Unique Transcriptional Programs

Dysregulation, But Not Mutation Of p53 Signaling Pathway In Breast Implant-Associated Anaplastic Large Cell Lymphoma Cell Lines

Enhancing Ceramide Cytotoxicity in Acute Myelogenous Leukemia

SF3B1 Mutations in CLL Are Equivalent to p53/ATM Dysfunction and Cause Defective Puma Upregulation in Response to Chemotherapy

ABT-737 Sensitizes B Cell Tumors for Killing by CD19-Retargeted T Cells,

Potent Synergistic Activity of the NAD+ Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.

Frequent Expression of MUC1, a Membrane-Associated Mucin, in Adult T-Cell Leukemia Cells.

Synergistic Apoptosis Induction by Betulinic Acid and Established Cytotoxic Drugs in Leukemia Cells.

The Immunotoxin HM1.24-ETA′ Is a Potent Inducer of Apoptosis in Malignant Plasma Cells

Dasatinib Is An Effective Inhibitor of Proliferation and Inducer of Apoptosis in the KASUMI Cell Line Bearing the T(8;21)(q22;q22) and the N822K KIT Mutation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only